Heron Therapeutics (HRTX) PT Lowered to $26 at Cantor Fitzgerald, After Receiving Complete Response Letter for HTX-011
Tweet Send to a Friend
Cantor Fitzgerald analyst Brandon Folkes ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
